The global non-surgical bio-implants market has set a valuation of US$ 27.8 Bn in 2021, and further, is expected to expand at a CAGR of 13.2% to reach US$ 96.0 Bn by the year 2032.
“Increasing adoption of bio-implant procedures and advancements in the bioengineering technologies is expected to uplift the non-surgical bio-implants market growth.”
An implant is a manufactured medical device that is inserted into a human body cavity to replace, support, or augment a biological structure that is missing, damaged, or already present. The prosthesis known as "bio-implants" are used to normalize a person's physiological functions.
The physiology that has been damaged, deregulated, or lost can be effectively restored, replaced, or modulated with injectable bio-implants, a non-surgical therapy approach. The number of people over the age of 60 and above resulted to continue the global trend of rising life expectancy and declining mortality rates.
Globally, the geriatric population is expanding faster than any other age group, demanding an effective and safe treatment for age-related conditions. This has grabbed the attention of non–surgical bio-implants.
Attributes
Details
Non-Surgical Bio-Implants Market Value in 2021
US$ 27.8 Billion
Non-Surgical Bio-Implants Market Value in 2032
US$ 96.0 Billion
Non-Surgical Bio-Implants Market CAGR (2022 to 2032)
13.2%
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
What Are The Major Drivers Boosting The Demand For Non-Surgical Bio-Implants Market?
The major drivers for the growth of the non-surgical implants market are growing concern for chronic disorders, a high level of healthcare awareness, and a growing geriatric population. In addition, the growing disposable incomes of people and the rising application areas majorly medical and aesthetic for biomaterials used in non-surgical bio-implants will attribute the market growth.
Furthermore, the advancements in technology in bio-implants and the affordable cost with easy availability of bio-implants are expected to have strong growth in the market. Apart from this, the demand for bio-implants in several medical applications is fuelling market growth.
Which Region Shows Strong Growth Potential In The Non-Surgical Bio-Implants Market?
Owing to a large number of key players and strong healthcare infrastructure, North America is expected to share the highest market for non-surgical bio-implants in the projected years.
Europe is the largest market for non-surgical bio-implants after North America due to the technological advancements in the region, along with increasing government support and funding and rising research and development activities.
Furthermore, due to the increasing geriatric population in the developing countries and high disposable income, the Asia Pacific region is expected to develop a lucrative market for non-surgical bio-implants market in near future.
Find your sweet spots for generating winning opportunities in this market.
Who Are The Key Players In The Non-Surgical Bio-Implants Market?
Some of the market players operating in the non-surgical bio-implants market are Albiorex International, Moma Therapeutics, Inc., FibroGen, Inc., KYTHERA Biopharmaceuticals, Inc., Novatex Bioengineering SA, Anika Therapeutics, Inc., Johnson & Johnson Private Limited, Fidia Farmaceutici S.p.A., LCA Pharmaceuticals, Hangzhou Gallop Biological Products Co., Ltd., and others.
Scope Of Report
Report Attributes
Details
Growth Rate
CAGR of 13.2% 2022 to 2032
Base Year for Estimation
2021
Historical Data
2012 to 2021
Forecast Period
2022 to 2032
Qualitative Units
Revenue in USD Billion, and CAGR from 2022 to 2032
Report Coverage
Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segment Covered
Type
Region
Region Covered
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa
Key Countries Profiled
USA
Canada
Brazil
Mexico
Germany
UK
France
Spain
Italy
China
Japan
South Korea
Malaysia
Singapore
Australia
New Zealand
GCC
South Africa
Israel
Key Players
Albiorex International
Moma Therapeutics, Inc.
FibroGen, Inc.
KYTHERA Biopharmaceuticals, Inc.
Novatex Bioengineering SA
Anika Therapeutics, Inc.
Johnson & Johnson Private Limited
Fidia Farmaceutici S.p.A.
LCA Pharmaceuticals
Hangzhou Gallop Biological Products Co., Ltd.
Customization
Available Upon Request
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Key Segments Covered In The Non-Surgical Bio-Implants Market Industry Survey
By Type:
Non-surgical Bio-implants
Viscoaugmentation Bio-implants
Viscosupplementation Bio-implants
Injectable Biomaterials
Collagen
Hyaluronan
Biopolymers
Hydrogels
Hydroxyapatite
Alloplastic Biomaterials
Acrylic Hydrogel
By Region:
North America
Latin America
Europe
East Asia
South Asia & Pacific
The Middle East and Africa (MEA)
Frequently Asked Questions
What is the Growth Outlook for the Global Non-Surgical Bio-Implants Market?
The global non-surgical bio-implants market is anticipated to register a CAGR of 13.2% during the forecast period.
Who are the Top Players in the Global Non-Surgical Bio-Implants Market?
The top players in the global non-surgical bio-implants market are Albiorex International Moma Therapeutics, Inc., FibroGen, Inc., KYTHERA Biopharmaceuticals, Inc., Novatex Bioengineering SA, and others.
